Home/Filings/4/0001127855-13-000158
4//SEC Filing

Asculai Samuel 4

Accession 0001127855-13-000158

CIK 0001395400other

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 2:22 PM ET

Size

4.7 KB

Accession

0001127855-13-000158

Insider Transaction Report

Form 4
Period: 2013-03-05
Asculai Samuel
DirectorCEO10% Owner
Transactions
  • Sale

    Common Stock

    2013-03-059,000,0008,015,834 total(indirect: By Biostrategies Consulting Group Inc.)

Issuer

Enhance Skin Products Inc

CIK 0001395400

Entity typeother

Related Parties

1
  • filerCIK 0001443569

Filing Metadata

Form type
4
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 2:22 PM ET
Size
4.7 KB